PDS Biotechnology Corporation (PDSB)

PDS Biotechnology Statistics

Total Valuation

PDSB has a market cap or net worth of $52.43 million. The enterprise value is $26.22 million.

Market Cap	52.43M
Enterprise Value	26.22M

Important Dates

The last earnings date was Thursday, March 27, 2025, before market open.

Earnings Date	Mar 27, 2025
Ex-Dividend Date	n/a

Share Statistics

PDSB has 45.40 million shares outstanding. The number of shares has increased by 17.77% in one year.

Current Share Class	37.41M
Shares Outstanding	45.40M
Shares Change (YoY)	+17.77%
Shares Change (QoQ)	+1.85%
Owned by Insiders (%)	3.12%
Owned by Institutions (%)	9.89%
Float	35.99M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.81
P/TBV Ratio	2.33
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	1.12
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-7.77

Financial Efficiency

Return on equity (ROE) is -156.28% and return on invested capital (ROIC) is -46.97%.

Return on Equity (ROE)	-156.28%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-46.97%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.50M
Employee Count	25
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-869,169
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -71.27% in the last 52 weeks. The beta is 1.67, so PDSB's price volatility has been higher than the market average.

Beta (5Y)	1.67
52-Week Price Change	-71.27%
50-Day Moving Average	1.38
200-Day Moving Average	2.49
Relative Strength Index (RSI)	40.49
Average Volume (20 Days)	795,374

Short Selling Information

The latest short interest is 3.86 million, so 8.49% of the outstanding shares have been sold short.

Short Interest	3.86M
Short Previous Month	4.67M
Short % of Shares Out	8.49%
Short % of Float	10.71%
Short Ratio (days to cover)	2.83

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-36.32M
Pretax Income	-45.29M
Net Income	-37.61M
EBITDA	-36.26M
EBIT	-36.32M
Earnings Per Share (EPS)	-$1.03

Balance Sheet

The company has $49.75 million in cash and $24.67 million in debt, giving a net cash position of $25.08 million or $0.55 per share.

Cash & Cash Equivalents	49.75M
Total Debt	24.67M
Net Cash	25.08M
Net Cash Per Share	$0.55
Equity (Book Value)	22.00M
Book Value Per Share	0.60
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PDSB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.77%
Shareholder Yield	-17.77%
Earnings Yield	-73.32%
FCF Yield	n/a

Analyst Forecast

The average price target for PDSB is $10.00, which is 765.80% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.00
Price Target Difference	765.80%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	95.71%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on March 18, 2019. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Mar 18, 2019
Split Type	Reverse
Split Ratio	0.05:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a